Seeing Is Believing
FOLD is currently covered by 7 analysts with an average price target of $15.4. This is a potential upside of $4.84 (45.83%) from yesterday's end of day stock price of $10.56.
Amicus Therapeutics's activity chart (see below) currently has 91 price targets and 72 ratings on display. The stock rating distribution of FOLD is 46.15% HOLD and 53.85% BUY.
Analysts average stock forecasts to be materialized ratio is 57.12% with an average time for these price targets to be met of 403.43 days.
Highest price target for FOLD is $22, Lowest price target is $15, average price target is $15.4.
Most recent stock forecast was given by ANUPAM RAMA from JPMORGAN on 18-Mar-2024.
Currently out of the existing stock ratings of FOLD, 6 are a HOLD (46.15%), 7 are a BUY (53.85%).
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
19
$7.4 (63.79%)
19
1 months 1 days ago
6/13 (46.15%)
$7.42 (64.08%)
454
Buy
22
$10.4 (89.66%)
1 months 21 days ago
0/4 (0%)
$9.18 (71.61%)
Hold
15
$3.4 (29.31%)
14
5 months 10 days ago
2/5 (40%)
$5.02 (50.30%)
275
Buy
18
$6.4 (55.17%)
14
6 months 22 days ago
2/4 (50%)
$6.14 (51.77%)
405
Buy
16
$4.4 (37.93%)
17
11 months 26 days ago
2/6 (33.33%)
$4.51 (39.25%)
578
What is FOLD (Amicus Therapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on FOLD (Amicus Therapeutics) with a proven track record?
Which analyst has the most public recommendations on FOLD (Amicus Therapeutics)?
Which analyst is the currently most bullish on FOLD (Amicus Therapeutics)?
Which analyst is the currently most reserved on FOLD (Amicus Therapeutics)?